drugset / Trial / NCT05577624
A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The primary objective of this study is to evaluate the pharmacokinetic (PK) profile of AMG 510 alone and in combination with rifampin in healthy participants.
Timeline
- Start
- 2019-11-05
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifampin | Small molecule | — | Oral |
| Subject | Sotorasib | Small molecule | — | Oral |
Indications
No indication recorded.